Polysaccharide vaccines against Haemophilus influenzae type B
Wysokińska, T.; Janaszek, W.
Przeglad Epidemiologiczny 48(1-2): 39-44
1994
ISSN/ISBN: 0033-2100 PMID: 8073141 Document Number: 428566
Epidemiological situation of Haemophilus influenzae infection was described. Conjugated polysaccharide vaccines used all over the world and available in Poland were discussed according to their efficacy and safety.
Document emailed within 1 workday
Related Documents
Schneerson, R.; Robbins, J.B.; Barrera, O.; Sutton, A.; Habig, W.B.; Hardegree, M.C.; Chaimovich, J. 1980: Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines Progress in Clinical and Biological Research 47: 77-94Parkkali, T.; Käyhty, H.; Ruutu, T.; Volin, L.; Eskola, J.; Ruutu, P. 1996: A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT Bone Marrow Transplantation 18(5): 961-967
Weinberg, G.A.; Murphy, T.V.; Granoff, D.M. 1990: Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease Pediatrics 86(4): 617-620
Black, S.B.; Shinefield, H.R. 1987: B-CAPSA i Haemophilus influenzae, type b, capsular polysaccharide vaccine safety Pediatrics 79(3): 321-325
Kristensen, K. 1989: Haemophilus influenzae type b vaccines Ugeskrift for Laeger 151(48): 3216-3218
Rümke, H.C.; Poolman, J.T. 1991: Conjugated vaccines against Haemophilus influenzae type b Nederlands Tijdschrift Voor Geneeskunde 135(1): 4-7
Rubin, L.G.; Voulalas, D.; Carmody, L. 1989: Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine Pediatrics 84(3): 509-513
Adderson, E.E.; Shackelford, P.G.; Quinn, A.; Carroll, W.L. 1991: Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide Journal of Immunology 147(5): 1667-1674
Solberg, C.O.; Brandtzeeg, P. 1995: Vaccine against Haemophilus influenzae type b. a new great achievement in the research on vaccines Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(13): 1597-1598
Yeh, S.J.; Huang, L.M.; Chen, J.M.; Lee, P.I.; Chang, L.Y.; Lin, Y.J.; Chiu, H.H.; Lee, C.Y. 1997: Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine Journal of the Formosan Medical Association 96(2): 110-115
Lucas, A.H.; Moulton, K.D.; Reason, D.C. 1998: Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide Journal of Immunology 161(7): 3776-3780
Cartwright, K.A.; Begg, N.T.; Rudd, P.T. 1994: Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease Communicable Disease Report. Cdr Review 4(2): R16-R17
Aleksandrowicz, J.; Fiejka, M.; Marciniak-Rusek, A. 1998: Level of bacterial endotoxins in Haemophilus influenzae type b vaccines conjugated with toxoids (td, Di) Medycyna Doswiadczalna i Mikrobiologia 50(3-4): 223-228
Cartwright, K.A.; Begg, N.T.; Rudd, P.T. 1994: Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease Communicable Disease Report. Cdr Review 4(2): R16-R17
Lenoir, A.A.; Granoff, P.D.; Granoff, D.M. 1987: Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants Pediatrics 80(2): 283-287
Suga, S.; Ishiwada, N.; Sasaki, Y.; Akeda, H.; Nishi, J.; Okada, K.; Fujieda, M.; Oda, M.; Asada, K.; Nakano, T.; Saitoh, A.; Hosoya, M.; Togashi, T.; Matsuoka, M.; Kimura, K.; Shibayama, K. 2018: A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan Vaccine 36(38): 5678-5684
1989: American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: update Pediatrics 84(2): 386-387
1990: American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: immunization of children at 15 months of age Pediatrics 86(5): 794-796
Mangtani, P.; Mulholland, K.; Madhi, S.A.; Edmond, K.; O'Loughlin, R.; Hajjeh, R. 2010: Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines Vaccine 28(7): 1677-1683
Kerdpanich, A.; Hutagalung, Y.; Watanaveeradej, V.; Bock, H.L.; Steinhoffmd, M. 2007: The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine Journal of the Medical Association of Thailand 90(7): 1330-1336